Prevention Clinical Trial
Official title:
Encouraging Overdue Healthcare Appointment Scheduling Among Patients With Chronic Diseases
NCT number | NCT05000619 |
Other study ID # | 2021-0442 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 12, 2021 |
Est. completion date | August 26, 2022 |
Verified date | November 2022 |
Source | Geisinger Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this study is to determine the most effective messages for encouraging patients with chronic conditions, who have not seen their doctor in at least one year, to return to the clinic. Study participants will receive postcards or letters encouraging them to make an appointment. Researchers will assess whether messages increase appointment scheduling (and attendance).
Status | Completed |
Enrollment | 21562 |
Est. completion date | August 26, 2022 |
Est. primary completion date | August 26, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Geisinger patient, Geisinger Health Plan member or Medicaid patient - Chronic illness - No appointment for > 1 year |
Country | Name | City | State |
---|---|---|---|
United States | Geisinger | Danville | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Geisinger Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Patients - Appointment scheduling - Comparing mailers | Proportion of Geisinger patients who schedule an appointment, comparing relative efficacy of the interventions. Note: this analysis will inform internal operations but will not be reported in publication. | 14 days | |
Other | Patients - Calls to scheduling line | Proportion of Geisinger patients who call the appointment scheduling line. | 30 days | |
Primary | Patients - Appointment scheduling | Proportion of Geisinger patients who schedule an appointment | 30 days | |
Secondary | Patients - Appointment scheduling - Comparing mailers | Proportion of Geisinger patients who schedule an appointment, comparing relative efficacy of the mailers | 30 days | |
Secondary | Patients - Attendance at scheduled appointments within 180 days of mailer | Proportion of appointments (from the primary outcome) that were attended. This outcome focuses on attendance at appointments that were scheduled within 30 days of the mailer drop date.
It is possible to schedule an appointment months in advance, so the Time Frame needs to be long to capture attendance at any appointment scheduled within 30 days of the mailer. 180 days should be sufficient to capture all scheduled appointments. |
180 days | |
Secondary | Patients, Members & Medicaid - Attendance at any appointment | Attendance at any appointment within 30 days of drop date | 30 days | |
Secondary | Patients, Members & Medicaid - Attendance at any appointment | Attendance at any appointment within 90 days of drop date | 90 days | |
Secondary | Patients, Members & Medicaid - Attendance at any appointment | Attendance at any appointment within 180 days of drop date | 180 days | |
Secondary | Patients, Members & Medicaid - Timing of appointment | Number of days between the drop date and any appointment captured in Secondary Outcome 3 | 30 days | |
Secondary | Patients, Members & Medicaid - Timing of appointment | Number of days between the drop date and any appointment captured in Secondary Outcome 4 | 90 days | |
Secondary | Patients, Members & Medicaid - Timing of appointment | Number of days between the drop date and any appointment captured in Secondary Outcome 5 | 180 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05509049 -
Precision Nudging Drives Wellness Visit Attendance at Scale
|
N/A | |
Active, not recruiting |
NCT05667974 -
A Study to Evaluate a PIKA Rabies Vaccine(Vero Cell)for Human Use,Freeze-dried
|
Phase 3 | |
Not yet recruiting |
NCT06335121 -
Implementation of PrEP Care Among Women in Family Planning Clinics
|
N/A | |
Not yet recruiting |
NCT04082091 -
Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
|
||
Terminated |
NCT01395238 -
Enhancing Father's Ability to Support Their Preschool Child
|
N/A | |
Completed |
NCT00535665 -
Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine
|
Phase 2 | |
Completed |
NCT00589173 -
An Interactive Preventive Health Record (IPHR) to Promote Patient-Centered Preventive Care
|
N/A | |
Completed |
NCT00814554 -
Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers
|
N/A | |
Completed |
NCT00995462 -
Prevention of Weight Gain in University Students
|
N/A | |
Completed |
NCT00966212 -
Parent Education for Young Teen Females
|
Phase 2/Phase 3 | |
Completed |
NCT04526873 -
Encouraging Annual Wellness Visits Among ACO Beneficiaries
|
N/A | |
Recruiting |
NCT06112249 -
SAFE Workplace Intervention for People With IDD
|
N/A | |
Completed |
NCT04977700 -
Using Physical Tracking to Predict Sunburn
|
N/A | |
Completed |
NCT04032145 -
Characterization of Health Conditions of Visitors of the Montreal Museum of Fine Arts
|
||
Completed |
NCT04785599 -
Lymphedema Prevention After Lymph Node Emptying
|
N/A | |
Recruiting |
NCT05050266 -
Enhancing Mental and Physical Health of Women Veterans
|
N/A | |
Recruiting |
NCT01021488 -
Rosuvastatin for Preventing Deep Vein Thrombosis
|
Phase 4 | |
Terminated |
NCT02247258 -
Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.
|
Phase 2 | |
Recruiting |
NCT05903885 -
A Cross-sectional Partnership to Improve Prevention
|
N/A | |
Completed |
NCT04162977 -
Adapting Personality-Targeted Interventions for Reducing Substance Misuse and Related Outcomes in Youth in Youth Protection Services
|
N/A |